SE8400283L - Sett att framstella virusstammar som stimulerer en verdorganisms naturliga forsvarsmekanism utan att samtidigt verka antigent - Google Patents
Sett att framstella virusstammar som stimulerer en verdorganisms naturliga forsvarsmekanism utan att samtidigt verka antigentInfo
- Publication number
- SE8400283L SE8400283L SE8400283A SE8400283A SE8400283L SE 8400283 L SE8400283 L SE 8400283L SE 8400283 A SE8400283 A SE 8400283A SE 8400283 A SE8400283 A SE 8400283A SE 8400283 L SE8400283 L SE 8400283L
- Authority
- SE
- Sweden
- Prior art keywords
- virus
- attenuated
- stimulate
- cattle
- dec
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title claims abstract 11
- 230000007246 mechanism Effects 0.000 title 1
- 230000037125 natural defense Effects 0.000 title 1
- 102000014150 Interferons Human genes 0.000 claims abstract 2
- 108010050904 Interferons Proteins 0.000 claims abstract 2
- 230000006698 induction Effects 0.000 claims abstract 2
- 229940079322 interferon Drugs 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims 3
- 238000010998 test method Methods 0.000 claims 2
- 101710186708 Agglutinin Proteins 0.000 claims 1
- 101710146024 Horcolin Proteins 0.000 claims 1
- 101710189395 Lectin Proteins 0.000 claims 1
- 101710179758 Mannose-specific lectin Proteins 0.000 claims 1
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 claims 1
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 claims 1
- 206010035148 Plague Diseases 0.000 claims 1
- 241000607479 Yersinia pestis Species 0.000 claims 1
- 239000000910 agglutinin Substances 0.000 claims 1
- 210000004102 animal cell Anatomy 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 238000009792 diffusion process Methods 0.000 claims 1
- 238000000760 immunoelectrophoresis Methods 0.000 claims 1
- 239000002799 interferon inducing agent Substances 0.000 claims 1
- 238000006386 neutralization reaction Methods 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 230000002238 attenuated effect Effects 0.000 abstract 3
- 241000283690 Bos taurus Species 0.000 abstract 2
- 208000010201 Exanthema Diseases 0.000 abstract 2
- 239000003085 diluting agent Substances 0.000 abstract 2
- 201000005884 exanthem Diseases 0.000 abstract 2
- 206010037844 rash Diseases 0.000 abstract 2
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 abstract 1
- 241000282887 Suidae Species 0.000 abstract 1
- 241000710959 Venezuelan equine encephalitis virus Species 0.000 abstract 1
- 239000007853 buffer solution Substances 0.000 abstract 1
- 244000309466 calf Species 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000016396 cytokine production Effects 0.000 abstract 1
- 239000008298 dragée Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 238000010255 intramuscular injection Methods 0.000 abstract 1
- 239000007927 intramuscular injection Substances 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000007922 nasal spray Substances 0.000 abstract 1
- 239000006218 nasal suppository Substances 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 230000002381 testicular Effects 0.000 abstract 1
- 241000712461 unidentified influenza virus Species 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 208000010484 vulvovaginitis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16732—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
- C12N2710/16764—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Virology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2161344A DE2161344C3 (de) | 1971-12-10 | 1971-12-10 | Herstellung von Virusstämmen, welche die natürlichen Abwehrmechanismen eines Wirtsorganismus stimulieren, ohne dabei gleichzeitig antigen zu wirken und Arzneimittel zur Prophylaxe und Behandlung von viralen und bakteriellen Infektionen des Menschen und der Tiere, einen solchen Virusstamm enthaltend |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8400283D0 SE8400283D0 (sv) | 1984-01-20 |
| SE8400283L true SE8400283L (sv) | 1984-01-20 |
Family
ID=5827622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8400283A SE8400283L (sv) | 1971-12-10 | 1984-01-20 | Sett att framstella virusstammar som stimulerer en verdorganisms naturliga forsvarsmekanism utan att samtidigt verka antigent |
Country Status (22)
| Country | Link |
|---|---|
| JP (2) | JPS6011013B2 (enExample) |
| AR (1) | AR204075A1 (enExample) |
| AT (1) | AT326817B (enExample) |
| AU (1) | AU473209B2 (enExample) |
| BE (1) | BE792484A (enExample) |
| BG (1) | BG21417A3 (enExample) |
| CA (1) | CA988848A (enExample) |
| CH (1) | CH577558A5 (enExample) |
| CS (1) | CS189587B2 (enExample) |
| DD (1) | DD108115A5 (enExample) |
| DE (1) | DE2161344C3 (enExample) |
| DK (1) | DK143201C (enExample) |
| ES (1) | ES409464A1 (enExample) |
| FR (1) | FR2162637B1 (enExample) |
| GB (1) | GB1356076A (enExample) |
| HU (1) | HU167086B (enExample) |
| IE (1) | IE36995B1 (enExample) |
| NL (1) | NL178014C (enExample) |
| PH (1) | PH12597A (enExample) |
| SE (1) | SE8400283L (enExample) |
| SU (1) | SU439956A3 (enExample) |
| ZA (1) | ZA728709B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0063657A1 (en) * | 1981-04-29 | 1982-11-03 | Merck & Co. Inc. | Topical application of interferon inducers |
-
0
- BE BE792484D patent/BE792484A/xx not_active IP Right Cessation
-
1971
- 1971-12-10 DE DE2161344A patent/DE2161344C3/de not_active Expired
-
1972
- 1972-01-01 AR AR245553A patent/AR204075A1/es active
- 1972-12-01 PH PH14135A patent/PH12597A/en unknown
- 1972-12-02 SU SU1853618A patent/SU439956A3/ru active
- 1972-12-05 JP JP47121265A patent/JPS6011013B2/ja not_active Expired
- 1972-12-05 JP JP47121264A patent/JPS5924137B2/ja not_active Expired
- 1972-12-06 BG BG022052A patent/BG21417A3/xx unknown
- 1972-12-07 NL NLAANVRAGE7216628,A patent/NL178014C/xx not_active IP Right Cessation
- 1972-12-07 CS CS728391A patent/CS189587B2/cs unknown
- 1972-12-07 AT AT1041972A patent/AT326817B/de not_active IP Right Cessation
- 1972-12-08 DK DK615472A patent/DK143201C/da not_active IP Right Cessation
- 1972-12-08 CA CA158,535A patent/CA988848A/en not_active Expired
- 1972-12-08 IE IE1716/72A patent/IE36995B1/xx unknown
- 1972-12-08 ZA ZA728709A patent/ZA728709B/xx unknown
- 1972-12-08 CH CH1791372A patent/CH577558A5/xx not_active IP Right Cessation
- 1972-12-08 GB GB5672372A patent/GB1356076A/en not_active Expired
- 1972-12-08 HU HUBA2833A patent/HU167086B/hu unknown
- 1972-12-08 FR FR7243868A patent/FR2162637B1/fr not_active Expired
- 1972-12-08 DD DD167455A patent/DD108115A5/xx unknown
- 1972-12-09 ES ES409464A patent/ES409464A1/es not_active Expired
- 1972-12-11 AU AU49920/72A patent/AU473209B2/en not_active Expired
-
1984
- 1984-01-20 SE SE8400283A patent/SE8400283L/sv not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wheelock | Virus replication and high-titered interferon production in human leukocyte cultures inoculated with Newcastle disease virus | |
| Yap et al. | Cytotoxic T cells specific for influenza virus-infected target cells | |
| Sugiura et al. | Genetic studies of influenza viruses: II. Plaque formation by influenza viruses in a clone of a variant human heteroploid cell line | |
| Vilček et al. | Differential effects of actinomycin D and puromycin on the release of interferon induced by double stranded RNA | |
| Bell Jr et al. | Immunization of mice against toxic doses of homologous elementary bodies of trachoma | |
| Sumbria et al. | Factors affecting the tissue damaging consequences of viral infections | |
| Levy-Koenig et al. | Immunology of Interferons: II. Heterospecific Activities of Human Interferons and Their Neutralization by Antibody | |
| Kim et al. | Abortive infection of human diploid cells by murine cytomegalovirus | |
| Jensen et al. | Studies of inhibitory effect of ammonium ions in several virus-tissue culture systems | |
| Melnick et al. | Immunogenic Potency of MgCl2—Stabilized Oral Poliovaccine | |
| GB1486186A (en) | Vaccines against feline leukaemia and the group of diseases associated with feline leukaemis/virus infection | |
| Mims | Rift Valley fever virus in mice. II. Adsorption and multiplication of virus | |
| Lavrov et al. | Combined inhibition of influenza virus reproduction in cell culture using interferon and amantadine | |
| Bradburne | An investigation of the replication of coronaviruses in suspension cultures of L132 cells | |
| SE8400283D0 (sv) | Sett att framstella virusstammar som stimulerer en verdorganisms naturliga forsvarsmekanism utan att samtidigt verka antigent | |
| IL28696A (en) | Attenuated live rubella virus vaccine and method of production | |
| Degre et al. | Production of an interferon-like agent following inoculation with bacterial vaccine | |
| Hirsch et al. | A new Salmonella type: Salmonella emek | |
| Yabe | Grouping of influenza bacilli | |
| GB1276218A (en) | Calf diarrhea virus vaccine and processes | |
| US3255081A (en) | Anti-viral vaccines immunized against oncogenic viruses | |
| Collins et al. | Interferon production and response to exogenous interferon in two cell lines of mouse brain origin persistently infected with Sendai virus | |
| Izawa et al. | A Mutant of Hog Cholera Virus in the Virus‐Carrier Cell Cultivated at a Lower Temperature | |
| Otsuki et al. | Antigenic variation of avian infectious bronchitis virus during replication in BHK-21 cells | |
| GB1413401A (en) | Influenza vaccine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8400283-1 Format of ref document f/p: F |